Safety and ImmunogenicityAmong Children Administered Quadrivalent Influenza Vaccine

StatusFinished
Effective start/end date9/11/109/11/11

Funding

  • Sanofi Pasteur, Inc.: $137,600.00

Keywords

  • Biotechnology & Drug Development